InvestorsHub Logo

zooey

08/09/23 7:25 AM

#2593 RE: DavidLeeRoth #2592

This is nice!

“…Food & Drug Administration (“FDA”) communicated that, following their initial review of the Company’s chronic toxicology program, the program’s studies appear adequate to support the safety of IMC-1 at the dose proposed by the Company for chronic use.”